Effect of ivabradine on cardiac arrhythmias: Antiarrhythmic or proarrhythmic?

Area of Science:

• Cardiology
• Pharmacology
• Electrophysiology

Background:

• Cardiac arrhythmias contribute significantly to mortality and morbidity.
• Current antiarrhythmic treatments, including drugs and devices, have limitations.
• Ivabradine, a selective heart rate-reducing agent, targets hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels.

Purpose of the Study:

• To review the clinical and basic science evidence for ivabradine's antiarrhythmic and proarrhythmic effects.
• To elucidate the mechanisms underlying ivabradine's actions on cardiac rhythm.
• To identify future research directions for ivabradine in arrhythmia management.

Main Methods:

• Literature review of clinical trials and basic science studies.
• Analysis of pharmacological data on ivabradine's interaction with HCN channels.
• Examination of evidence regarding both therapeutic and adverse electrophysiological effects.

Main Results:

• Ivabradine demonstrates selective heart rate reduction.
• Evidence suggests both antiarrhythmic and potential proarrhythmic effects of ivabradine.
• Mechanisms involve the inhibition of HCN channels, impacting cardiac automaticity.

Conclusions:

• Ivabradine's role in arrhythmia treatment requires further investigation.
• Understanding its dual effects is crucial for optimizing its therapeutic application.
• Future studies should focus on precise mechanisms and clinical outcomes in diverse arrhythmia types.